HDAC9 and ovarian carcinoma: In the present study, we investigated the effect of a HDAC inhibitor, PS by using GCT and ovarian cancer cell lines and demonstrated that PS exerted anti-proliferative effect mainly by apoptosis and also possess another potency such as activation of adherens junction toward a normalized direction.